Treatment of esophageal cancer with lapatinib tosylate
摘要
Disclosed is the use of N-{3-chloro-4-[(3-fluorobenzyl) oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine tosylate in the manufacture of a medicament for the treatment of an EGFR and/or erbB2 overexpressing esophageal cancer.
申请公布号
NZ551622(A)
申请公布日期
2010.01.29
申请号
NZ20050551622
申请日期
2005.06.01
申请人
SMITHKLINE BEECHAM (CORK) LIMITED
发明人
BERGER, MARK S;EL-HARIRY, IMAN;GILMER, TONA MORGAN;RUSNAK, DAVID;SPECTOR, NEIL L;PANDITE, ARUNDATHY NIRMALINI
